Glooko

As 2025 comes to a close, it is clear that this has been a defining year for Glooko and for the broader evolution of diabetes care. Following the close of our Series F, we entered the year with a clear focus: deliver on our strategy, expand our global impact, and continue building technology that helps make diabetes care more connected, actionable, and human.

Accelerating our Mission through Strategic Leadership and a Connected Care Continuum

Over the past year, we reached several important milestones in support of that goal. We expanded our capabilities through the acquisition of Monarch Medical Technologies and its EndoTool Glucose Management System, bringing together complementary capabilities across outpatient and inpatient diabetes and glycemic management.

We strengthened our ecosystem with the launch of our Abbott FreeStyle Libre integration in the U.S., helping ensure that critical glucose data can flow more seamlessly to people with diabetes and their care teams.

We also reinforced our clinical leadership with the appointment of Mark Clements, M.D., Ph.D., as Chief Medical and Strategy Officer, underscoring our commitment to evidence-based innovation and strong clinical partnership.

Driving Digital Health Adoption in EMEA

We also saw meaningful traction across geographies and care settings.

In EMEA, we continued to expand our presence as health systems look for scalable, interoperable digital solutions to support diabetes care. At the same time, Glooko XT, our remote monitoring solution available only in France, introduced new features and strengthened its gestational diabetes management capability, an area where timely insights and coordinated care are critical for both maternal and fetal outcomes. These areas of momentum reflect the growing demand for digital tools that can support diverse patient populations and clinical workflows.

Further Enhancing our Diabetes Management Platform to Improve Care

On the product front, we continued to invest in tools designed for the realities of care delivery.

The launch of the new Glooko clinic dashboard marked an important step forward in helping clinics and health systems move beyond raw data to clearer insights, enabling more informed, timely decisions at the point of care. Across the organization, we remained focused on bringing teams together around a shared mission and shared standards, ensuring that our growth continues to be purposeful and aligned.

A reality faced by care teams each day is the need for timely, actionable data within existing clinical workflows. That’s why we invested further into our EHR capabilities this year and joined the Epic Showroom to make it easier for hospitals and health systems to seamlessly integrate their EHR with Glooko, helping reduce clinician burnout and optimize clinical workflows.

The Glooko Mobile App for people with diabetes also continued to innovate in 2025 with a redesigned food tracker for more insightful nutrition data and insights, revised insulin cards for more clarity, and viewable GLP-1 doses. These enhancements enable care teams to make more informed and timely treatment decisions between appointments using their patients’ health data – all viewable in one place.

How the U.S. Healthcare System is Moving Toward Data-Driven, Accountable Diabetes Care

These milestones matter, but they are occurring against a broader backdrop of change in healthcare that strongly validates this direction. The latest American Diabetes Association’s Standards of Care reinforce what clinicians and people with diabetes have long understood: technology-enabled management and data-driven insights are now foundational to delivering high-quality diabetes care.

At the same time, policy initiatives such as the CMS ACCESS program signal a growing emphasis on interoperability, data liquidity, and the responsible use of health data to improve outcomes at scale.

Together, these shifts point to a future in which diabetes care is increasingly proactive rather than reactive, and where data is not simply collected, but translated into meaningful action.

Regulatory momentum is reinforcing the importance of consistent, evidence-based glycemic management across care settings. CMS’s upcoming electronic clinical quality measure (eCQM) requirements for inpatient glycemic management, expected to take effect in 2026, reflect a growing emphasis on standardization, measurement, and accountability in hospital-based diabetes care. Solutions like EndoTool are at the forefront of this shift, helping health systems operationalize best practices, support clinical decision-making, and drive more reliable glycemic outcomes at scale.

For healthcare providers and care teams, this evolution brings both opportunity and urgency. As care becomes more continuous and data-rich, success depends on having tools, like Glooko’s EHR integrations, that reduce complexity, surface what matters most, and fit naturally into clinical workflows. The goal is not more data for its own sake, but clearer insight that supports better decisions and more personalized care.

For health systems, the focus is expanding to population-level impact. Managing chronic disease across diverse populations requires platforms that enable earlier intervention, more consistent care, and coordination across settings. Interoperable digital solutions, like Glooko, are becoming essential infrastructure for balancing quality, efficiency, and cost in an increasingly complex care environment.

Leveraging Scalable Healthcare Technology to Deliver Consistent Diabetes Care Around the World

Globally, the stakes are even higher. Diabetes prevalence continues to rise across regions with very different healthcare resources and delivery models. Scalable digital health solutions offer a path to extend evidence-based care, support clinicians, and bring greater consistency to diabetes management worldwide. As global standards and policies evolve, technology will play a central role in enabling more equitable access to high-quality care.

The Road Ahead for Glooko

Looking ahead, our focus at Glooko remains clear. We will continue investing in platforms that turn diabetes data into insight, insight into action, and action into better outcomes. We will deepen partnerships across the ecosystem and stay closely aligned with clinicians, health systems, and people with diabetes as their needs continue to evolve.

2025 was a year of momentum for Glooko. More importantly, it reinforced why our mission matters. As the future of diabetes care continues to take shape, we are energized by the opportunity to help lead the way.

We are proud to share that Glooko has been recognized by The Healthcare Technology Report as one of the Top 50 Healthcare Technology Companies of 2025. This honor reflects the progress we are making toward building a more connected, personalized, and accessible future for people with diabetes and the clinicians who support them.

Each year, this list highlights organizations that are shaping the trajectory of healthcare through innovation and meaningful impact. For Glooko, this recognition reinforces the work taking place across our teams to simplify the complexity of diabetes care. Whether it is bringing data from devices into a single platform, supporting timely clinical decision making, or expanding digital tools that help people manage their diabetes with confidence, our mission has remained constant. We aim to improve patient outcomes through connected care platforms that work in the real world.

This award also reflects how far we have come in strengthening our portfolio. From the continued evolution of the Glooko platform, to the future integration of the inpatient insulin dosing technology of EndoTool, developed by Monarch Medical Technologies, a Glooko Company, to our partnerships that expand clinical value and accessibility, we are building an innovative approach to diabetes management that spans the full care journey. These advancements are the direct result of our teams’ expertise and commitment to the people who rely on our products every day.

Most importantly, this recognition is a reminder of why we do this work. Behind every data point is a person managing a lifelong condition while balancing the demands of life, family, and care. Our responsibility is to meet them where they are with tools that are intuitive, reliable, and informed by real clinical needs.

We are honored to be included among so many forward-thinking healthcare technology leaders. As we look to 2026, we remain focused on delivering solutions that empower clinicians, support health systems, and make life better for people with diabetes around the world.

Through our ongoing commitment to enhancing diabetes care and simplifying diabetes management, we launched a redesigned food tracking experience in the Glooko Mobile App, making logging faster, more flexible, and even more insightful.

This powerful upgrade, featured in the Glooko Web App 25.3 and Mobile 6.13 release, is designed with the core purpose of making it easier for people with diabetes to log meals and for clinicians, endocrinologists, and the entire care team to streamline reviewing nutrition data alongside glucose trends, insulin doses, and exercise.

The new interface transforms the meal logging process, ensuring people with Type 1 diabetes, Type 2 diabetes, gestational diabetes, and prediabetes are more engaged with their nutrition tracking than ever before. For clinicians, the tool delivers the rich, contextual data needed for more impactful appointments and timely, data-backed interventions.

Ways for Easier and More Flexible Food Logging

The goal of the redesign was simple: make tracking food as quick and intuitive as possible for Glooko Mobile App users with diabetes. The new mobile experience allows users to:

Log Meals by Type: Start by simply selecting a meal type (breakfast, lunch, dinner, or snack).
Multiple Input Methods: Add food items instantly through a variety of convenient methods:
- Manual search of our expansive database of food items (Select languages only)
- Barcode scanning (U.S. only)
- Voice input (Select languages only)
- Quick add from our food database or through custom entry
Customize and Save Favorites: App users can now create custom food entries and easily mark meals or food items as favorites with a single tap of a heart for lightning-fast logging next time.
Review Before Saving: The ability to edit existing items for time, data, and serving size, or review the full meal with detailed nutritional summaries ensures accuracy before the data is saved.
View the Summary: A nutritional summary now appears after each logged meal to help users better understand their daily intake.

Providing Smarter Nutrition Insights and Visualizations

The new design goes beyond logging to provide users with a clearer picture of their diet composition:

Track Macro Distribution: The Glooko Mobile App now tracks the distribution of carbs, fat, and protein as a percentage of total calories per day. This vital feature helps users quickly assess if macro intake aligns with dietary goals and how it may be influencing glucose patterns.
Data-Packed Charts and Graphs: The simplified logging process means more consistent data, which is viewable in the Daily Log and a new Food Graph below the Carbs section of Charts and Graphs, allowing users to better understand diet-related glucose fluctuations and discuss potential changes with their care teams.
Enhanced Meal Visualization: Users and care teams can now view added meals directly in the History List of the Glooko web app, with each entry displaying the exact meal type, nutritional information, and details of the included food. This enhanced visualization provides a better understanding of how nutrition works together with insulin doses, exercise, medications, and weight. Previous views of carbs are still available in the Overview Graph, Daily Graph, Weekview, and Calendar.

A Comprehensive Approach to Diabetes Management

This revamped food tracking experience is more than just an update — it’s a powerful tool designed to foster better patient engagement and deliver insightful data people with diabetes and their healthcare providers need to manage diabetes more effectively.

With nutrition, exercise, medication, lifestyle management, and other health data, we’re creating a better way to manage diabetes. To get started, download the Glooko Mobile App on the App Store and the Google Play Store today.

*Not all product features are available in all countries.

We are thrilled to be an exhibitor at the ADCES Diabetes Technology Conference (DTC25) in Chicago on December 12 and 13. This unique event focuses on how cutting-edge technology, like Glooko, can empower diabetes care teams and improve outcomes for people with diabetes.

During the show, we’ll share at table #18 how Glooko delivers essential clinical advantages. Attendees will see firsthand how our diabetes management software, compatible with more than 200 diabetes and health monitoring devices and apps, enables care teams to effortlessly analyze patient data, streamline care coordination, and tailor interventions that can lead to improved health outcomes.

Here’s what we’ll showcase at DTC25:

New Glooko Clinic Dashboard: Designed specifically for busy healthcare providers, the new dashboard in Glooko offers an organized, at-a-glance view of patient trends and crucial clinic metrics. This powerful tool enables care teams to make more informed treatment decisions and build a stronger clinic strategy.
Seamless EHR Integrations: Glooko streamlines clinical workflows by integrating securely with leading EHR systems. This functionality eliminates the need for healthcare providers to switch platforms, giving care teams a complete, centralized view of all diabetes and related health data within a single, familiar interface, allowing them to work more efficiently.
EndoTool Glucose Management System, developed by Monarch Medical Technologies, a Glooko Company: Recently acquired by Glooko, EndoTool is the leading patient-specific inpatient insulin-dosing software trusted by 8 of the top 10 U.S. health systems to support safer, more consistent glycemic management at the bedside.

Elevate your practice with our innovative diabetes management platform

Ready to see how Glooko can elevate your clinic? Schedule a meeting with one of our experts at DTC25.

EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions. Patient-specific refers to EndoTool’s ability to use available patient information within the hospital’s electronic medical record to provide individualized insulin dosing recommendations. Recommendations are intended to assist, not replace, clinical judgment. All treatment decisions remain the responsibility of the licensed healthcare provider.

At Glooko, we believe that people living with diabetes are the ultimate experts in their own care. This driving principle is the heartbeat of our mission and is deeply woven into our company culture. Nowhere is this more evident than in our diabetes-focused employee resource group (ERG), the Glucose Gladiators. They ensure we live our mission daily by putting the voice of the user at the center of innovation, driving us to improve diabetes care.

Embedding Real-World Diabetes Perspectives into Glooko

Recognizing the critical need to embed real-world experience into our work, a group of employees living with diabetes came together to found the Glucose Gladiators, a vibrant internal community dedicated to connection and support. The ERG is remarkably diverse, including people with Type 1 and 2 diabetes, caregivers, former nurses and healthcare providers, and women who experienced gestational diabetes. Their firsthand perspectives are our greatest asset. By sharing their personal experiences, Glooko is better equipped as a company to create a diabetes management solution that truly resonates and fulfills our core mission.

The ERG’s purpose is to:

Educate other employees at Glooko about the realities of life with diabetes.
Foster cross-department collaboration that drives meaningful impact in diabetes care.
Help evolve our diabetes management platform to better serve the real-world needs of our users. By sharing their personal insights with our product team, we ensure our platform truly makes a difference.

Inside Look at the Glucose Gladiators’ Mission and Initiatives

Want to hear firsthand about the Glucose Gladiators’ impact? Meet Hadley Horton, a Senior Partner Manager at Glooko and a proud member of our ERG. Having lived with Type 1 diabetes since 2009, Hadley shares how the group’s personal experiences fuel their passion for improving the lives of others in the diabetes community.

MKT-0467

Healthcare providers struggle to manage large diabetes populations without a comprehensive view of patient data.

During this webinar, Glooko Chief Medical and Strategy Officer Mark Clements, MD, PhD, and Glooko Senior Clinical Transformation Director Trisha Martinez, BSN, MBA, RN, explore the new Glooko clinic dashboard, a powerful tool designed to streamline diabetes population health management and enable smarter care across hospitals, health systems, and clinics.

Our clinical experts take a deep dive into this user-friendly dashboard, available in select countries, and showcase its at-a-glance insights into patient trends and key clinic metrics that can help care teams easily interpret complex data for more efficient decision-making.

Ready to optimize diabetes population health management?

Contact Team Glooko for a demo of our new clinic dashboard, which helps healthcare teams manage large diabetes populations more effectively by prioritizing care and boosting patient engagement.

MKT-0468

During this Glooko 101 webinar, Glooko Senior Director of Clinical Transformation Trisha Martinez, BSN, MBA, RN, helps healthcare providers, including endocrinologists, nurses, and certified diabetes care and education specialists, get the most out of their professional Glooko account, reviewing core features and tools that support clinical workflows for both new users and those looking for a refresher.

This session also covers best practices for onboarding patients with diabetes using continuous glucose monitors (CGMs), including how to connect CGM data to Glooko to ensure seamless access to glucose trends and actionable insights from day one.

Time to Optimize your Diabetes Practice

Book a one-on-one session with Team Glooko today to better understand how to optimize Glooko from the start, get customized guidance on connecting CGM data, and gain access to actionable glucose trends care teams need.

MKT-0473

The role of certified diabetes care and education specialists (CDCESs) is vital in helping people with diabetes manage their condition, achieve optimal health outcomes, and thrive.

Glooko’s innovative web platform and mobile app is designed to make diabetes care and education more efficient, data-driven, and impactful for these critical care team members.

By providing cutting-edge capabilities, Glooko empowers CDCESs at hospitals, health systems, and clinics to support patients’ diabetes management, reduce the risk of complications, and improve health outcomes.

Advantages of CDCESs Leveraging Glooko

Glooko offers a range of features in its platform that streamlines clinical workflows, enhances the decision-making for CDCES professionals and the entire diabetes care team, and ultimately, supports better diabetes management and care:

Expansive Device Compatibility: Glooko seamlessly integrates with over 200 diabetes and health monitoring devices and apps, centralizing relevant health data and making it easily accessible.
Clinic Dashboard for Diabetes Population Health Management: Our new clinic dashboard, available in select countries, provides CDCESs with at-a-glance insights of a clinic’s diabetes patient population, leading to more efficient, data-driven decisions.
Seamless EHR Integrations: Our integrations with leading electronic health records (EHRs), including Epic, Oracle Health, MEDITECH, Greenway Health, eClinicalWorks, NextGen, and Athenahealth, securely centralizes diabetes and related health data, giving CDCESs a complete view of a patient’s health in one place and eliminating the hassle of platform switching and multiple logins.
Educational Digital Care Programs: Glooko’s care programs complement the work of the CDCES by providing patients with structured education that advances their understanding of diabetes management.
Easier Log-in with SSO: Single Sign-On (SSO) eliminates the need for multiple logins and passwords, cutting credential hassle so CDCESs can focus more time on delivering high-quality patient care.
Exceptional Customer Support: Backed by rapid response times, an extensive help center, and U.S.-based support, CDCESs can spend less time troubleshooting technical issues and more time focused on their patients.

Glooko Advances the ADCES7 Self-Care Behaviors®

Diabetes Self-Management Education and Support (DSMES) is a program from the Association of Diabetes Care and Education Specialists (ADCES) designed to empower individuals with diabetes to manage their condition effectively. It’s structured around the ADCES7 Self-Care Behaviors, which represent seven critical areas of diabetes self-management.

CDCES professionals partner with patients with diabetes to help prioritize and improve their own management skills across these seven essential behaviors. CDCESs can leverage the Glooko Mobile App, which supports patients in tracking and managing each of these behaviors, to complement their own education and guidance:

Healthy Eating: People living with diabetes can enter food into the Glooko Mobile App to better understand how nutrition affects their condition and well-being.
Being Active: The app allows tracking of steps, fitness, and other exercises, helping users understand the impact of physical activity on their overall health and glycemic control.
Taking Medication: Patients can track medication, set reminders, and enter notes about the impact of medications, which can be shared with care teams.
Reducing Risk: Through its manual entry feature and compatibility with smart scales and blood pressure cuffs, the Glooko Mobile App can be used to monitor trends in weight and blood pressure.
Problem Solving: The app helps users identify patterns in everything from nutrition and weight to insulin and glucose levels and solve challenges independently or through remote collaboration with their car team.
Healthy Coping: People with diabetes can record notes in the Glooko Mobile App about their feelings, beliefs, challenges, and successes while managing their diabetes.

Users of the Glooko Mobile App also can access our comprehensive support center for troubleshooting and helpful tips, allowing them to make the most of the app’s features.

Enhance the CDCES-Patient Experience with Glooko

At Glooko, we provide CDCES professionals with digital health tools for simpler diabetes management and better health outcomes for their patients.

Find out how Glooko’s diabetes management software can support your care team’s delivery of data-driven, high-quality care by scheduling a demo.

Two years ago, my life changed when I was diagnosed with Type 1 diabetes (T1D).

I was 28, and the path to a correct diagnosis was a frustrating battle lasting many months. My primary care doctor initially told me I was “too old” for T1D, so she suspected I potentially had Type 2 diabetes and prescribed basal insulin, metformin, and a BG meter. I initially refused the medication, but began testing my blood glucose. After reaching a level of 650 mg/dL, I accepted the diagnosis and started the medication. It was a turbulent time as I was losing weight and struggling, but I eventually accepted my new reality as a person living with diabetes after my blood work and my first endo appointment.

Today, I’m a completely different person who is now thriving while living with diabetes, fueled by an optimistic outlook and the amazing technology that has made my daily management a total game-changer.

Diabetes Technology Giving Me Control

I honestly don’t have to “think about” my diabetes much anymore, except when I’m eating a carb-heavy meal or exercising. The reason? The powerful diabetes devices I use every day, including:

The Dexcom G7 gives me continuous blood sugar readings, which means I no longer have to prick my finger every 20 minutes. That alone is a massive win.
The Omnipod 5 is my insulin pump, managing both my basal background and bolus mealtime insulin dosing, essentially acting as an external pancreas.
Glooko is my true secret weapon. I love that the mobile app pulls data from my Omnipod, Dexcom G7, and even Apple Health into one place. This makes it incredibly easy for me to track patterns, and it’s an essential tool for my endocrinology team who can review my daily trends and help me fine-tune my care. Knowledge gives you control, and having all my health data centralized is the ultimate power-up.

Passion to Purpose: My Rewarding Journey with Team Glooko

Before I joined Team Glooko, I was already passionate about the diabetes space, staying up to date on new devices and scientific breakthroughs. That’s what drew me to Glooko’s mission to transform diabetes care for healthcare providers and people living with diabetes. Working here has been one of the most rewarding journeys of my life. The community, including the Glucose Gladiators, our employee resource group for people living with diabetes, is highly motivated to make life better for patients and clinicians alike.

It’s a Marathon, Not a Sprint

If I could give some advice to someone newly diagnosed, it would be this: Take it one day at a time and educate yourself. Also, be kind to yourself as it’s okay to have off days. Managing diabetes is a marathon, not a sprint, and you are not alone.

For anyone who doesn’t live with this chronic condition, I want you to know that diabetes feels more like a full-time job than a debilitating disease. Managing blood sugar is a complex, day-to-day process influenced by sleep, stress, exercise, diet, and hormones. It’s a constant juggling act — like a game — where you have to learn from both your wins and your mistakes.

To keep my blood sugar balanced and help make living with diabetes a bit easier on myself, I primarily focus on eating a minimal carb diet with plenty of meat and vegetables. My ultimate go-to meal is sashimi because it’s lean, delicious, and doesn’t require me to bolus insulin. This healthy eating plan works perfectly alongside resistance training and my daily routine, which includes walking my rescue dog, Dude, as the perfect, stress-free way to incorporate consistent, low-impact physical activity.

Major Takeaways on Living with T1D

Looking ahead, while a cure would be incredible, I think advancing diabetes technologies, like making CGMs and insulin pumps even more discreet and reliable, will have a huge impact on quality of life.

Ultimately, I think a lot about the insulin and variety of diabetes technologies we have today that make it possible for me to lead a full, normal life. Not more than a century ago, a diagnosis like mine was essentially a death sentence. I am incredibly grateful to have been diagnosed at a time when insulin therapy is available, technology makes managing my diabetes so streamlined and, thanks to the data Glooko provides, even simpler.

As we recognize Diabetes Awareness Month, I feel really optimistic about the future and the power of data to help endocrinologists improve care even more!

We’re thrilled to share that Glooko will be exhibiting at the 25th Annual Diabetes Technology Meeting (DTM), co-presented by the Diabetes Technology Society (DTS) and the American Diabetes Association, from October 28 to 30 in San Francisco, California.

At the diabetes industry event, we’ll showcase how our cutting-edge digital health platform is transforming care for people living with diabetes and their healthcare providers. Team Glooko is also looking forward to connecting with leading experts and innovators from around the globe as they explore the latest advancements shaping the future of diabetes technology.

Some of the exciting features and happenings that attendees will see at booth #15:

New Glooko Clinic Dashboard: The dashboard, designed for busy healthcare providers, offers a clear, organized view of patient trends and key clinic metrics based on TIDE metrics developed by Stanford. This new tool helps care teams interpret complex data at-a-glance, allowing them to make more efficient decisions for their patients with diabetes and develop a more effective clinic strategy.
EndoTool Glucose Management System, developed by Monarch Medical Technologies, a Glooko Company: EndoTool, recently acquired by Glooko, is the only patient-specific insulin dosing system designed to simplify glycemic management in hospitals. Its unique algorithm models each patient’s clinical characteristics and response to insulin, delivering optimal dosing recommendations to reduce the risk of severe hypoglycemia.
Industry-Leading Device Compatibility: Glooko seamlessly connects to an extensive ecosystem of more than 200 diabetes and health monitoring devices and apps, allowing people with diabetes to sync and share their health data with their care teams to enable better treatment decisions.
EHR Integrations: Glooko integrates with leading EHR systems to securely centralize diabetes data, eliminating the need for healthcare providers to switch platforms. This innovative functionality allows care teams to work more efficiently using a single interface with a complete view of their patients’ health data.

Expert Insights on the Power of Diabetes Health Data

Don’t miss the Actionable Data presentation given by Glooko Chief Medical and Strategy Officer Mark Clements, MD, PhD, at 1:30 p.m. PT on October 28. The presentation will offer deep insights into leveraging data to drive better outcomes in diabetes care.

Temple Health to Present New Data on Patient-Specific Subcutaneous Insulin Dosing

A highly anticipated poster,”Safety and Efficacy of a Patient-Specific Inpatient Dosing Application for Subcutaneous Insulin,” will present new evidence from Temple University Health System and Lewis Katz School of Medicine supporting the safety and efficacy of patient-specific insulin dosing for hospitalized patients on subcutaneous insulin. This study highlights outcomes from using the EndoTool SubQ application from Monarch Medical Technologies. The poster will be revealed at 4:30 p.m. PT on October 28.

Enhance Connected Care with Glooko

To find out more about our diabetes management platform from one of our experts at DTM 2025, schedule a meeting.